Who knows why different people have different symptoms with the common cold? Well, a new study used laboratory-grown noses ...

Even after surgery and chemotherapy, some cancers, like pancreatic and colorectal, maintain a foothold in the body and ...

Life Extension reports women live 5.4 years longer than men due to biological and behavioral factors, but men can narrow this ...

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.

Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...

Overall, MajesTEC-3 signals a meaningful step forward for combination bispecific therapies in multiple myeloma, while ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

The field of tumor microenvironment research has increasingly highlighted the intertwined relationship between aberrant vasculature and dysregulated immune ...